Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5895
    -0.0010 (-0.18%)
     
  • NZD/EUR

    0.5526
    -0.0019 (-0.34%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    82.13
    -0.60 (-0.73%)
     
  • GOLD

    2,393.20
    -4.80 (-0.20%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,844.66
    -32.39 (-0.41%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,750.05
    -87.35 (-0.49%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    91.1320
    -0.1220 (-0.13%)
     

Drugmaker Shire's $30 bln Baxalta bid

Drugmaker Shire says it's seeking to buy Baxalta, a company spun-off by Baxter International last month, for $30 billion to forge the leading global specialist in rare diseases. As Joel Flynn reportsthe London-listed group went public with its approach after the U.S. firm turned it down.